Evidence map›Paper›PMID 32340142›Full record

ArticleMolecules (Basel, Switzerland)2020

A New Italian Purple Corn Variety (Moradyn) Byproduct Extract: Antiglycative and Hypoglycemic In Vitro Activities and Preliminary Bioaccessibility Studies.

Lucia Ferron, Raffaella Colombo, Barbara Mannucci, Adele Papetti

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Nutrients · 2025
    Article
  3. Effects ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. Article
  6. Phenolic Characterization of a Purple Maize (Journal of agricultural and food chemistry · 2024
    Article
  7. Quality, Safety and Biological Studies onPharmaceuticals (Basel, Switzerland) · 2023
    Article
  8. Article
  9. Valorization of Rice Husk (Foods (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lucia FerronDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
Raffaella ColomboDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0001-9675-6598
Barbara MannucciCentro Grandi Strumenti, University of Pavia, Via Bassi 21, 27100 Pavia, Italy.ORCID 0000-0002-7371-7243
Adele PapettiDepartment of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.ORCID 0000-0003-1523-7759
University of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reuse of byproducts from agricultural and food industries represents the key factor in a circular economy, whose interest has grown in the last two decades. Thus, the extraction of bioactives from agro-industrial byproducts is a potential source of valuable molecules. The aim of this work was to investigate the in vitro capacity of byproducts from a new Italian corn variety, named Moradyn, to inhibit the accumulation of advanced glycation end products (AGEs) involved in several chronic age-related disorders. In addition, the hypoglycemic effect of Moradyn was tested by in vitro enzymatic systems. A Moradyn phytocomplex and its purified anthocyanin fraction were able to inhibit fructosamine formation and exhibited antiglycative properties when tested using BSA-sugars and BSA-methylglyoxal assays. These properties could be attributed to the polyphenols, mainly anthocyanins and flavonols, detected by RP-HPLC-DAD-ESI-MS

Indexed as

alpha-GlucosidasesChromatography, High Pressure LiquidGlycation End Products, AdvancedGlycolysisGlycoside Hydrolase InhibitorsHypoglycemic AgentsMass SpectrometryMolecular StructurePhytochemicalsPlant ExtractsZea maysalpha-GlucosidasesGlycation End Products, AdvancedGlycoside Hydrolase InhibitorsHypoglycemic AgentsPhytochemicalsPlant Extractsadvanced glycation end productsanthocyaninsantiglycative capacitycircular economyhypoglycemic effectin vitro simulated digestion processpolyphenolspurple corn byproductZea mays L.

Identifiers

PMID32340142
PMCPMC7221992
OpenAlexW3019073861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.